Embolisation of PAVMs reported to improve nosebleeds by a subgroup of patients with hereditary haemorrhagic telangiectasia

Claire L Shovlin, Trishan Patel, James E Jackson, Claire L Shovlin, Trishan Patel, James E Jackson

Abstract

Pulmonary AVM embolisation appears to improve nosebleed severity for nearly one in six people with HHT http://ow.ly/4mJqip.

Conflict of interest statement

Conflicts of Interest: None declared

Figures

FIGURE 1
FIGURE 1
Reported effects of investigations and treatments on hereditary haemorrhagic telangiectasia (HHT) nosebleeds. Note that treatments reported by small numbers of patients are not represented graphically. BP: blood pressure; PAVM: pulmonary arteriovenous malformation. **: p

References

    1. Shovlin CL. Pulmonary arteriovenous malformations. Am J Respir Crit Care Med 2014; 190: 1217–1228.
    1. Santhirapala V, Williams LC, Tighe HC, et al. . Arterial oxygen content is precisely maintained by graded erythrocytotic responses in settings of high/normal serum iron levels, and predicts exercise capacity: an observational study of hypoxaemic patients with pulmonary arteriovenous malformations. PLoS One 2014; 9: e90777.
    1. Howard LS, Santhirapala V, Murphy K, et al. . Cardiopulmonary exercise testing demonstrates maintenance of exercise capacity in hypoxemic patients with pulmonary arteriovenous malformations. Chest 2014; 146: 709–718.
    1. Shovlin CL, Chamali B, Santhirapala V, et al. . Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and platelets. PLoS One 2014; 9: e88812.
    1. Kjeldsen AD, Tørring PM, Nissen H, et al. . Cerebral abscesses among Danish patients with hereditary haemorrhagic telangiectasia. Acta Neurol Scand 2014; 129: 192–197.
    1. Post MC, Thijs V, Schonewille WJ, et al. . Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine. Neurology 2006; 66: 202–205.
    1. Finnamore H, Le Couteur J, Hickson M, et al. . Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency. PLoS One 2013; 8: e76516.
    1. Livesey JA, Manning RA, Meek JH, et al. . Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli/deep venous thromboses in replicate cohorts of patients with hereditary hemorrhagic telangiectasia. Thorax 2012; 67: 328–333.
    1. Vorselaars VM, Velthuis S, Mager JJ, et al. . Direct haemodynamic effects of pulmonary arteriovenous malformation embolisation. Neth Heart J 2014; 22: 328–333.
    1. Elphick A, Shovlin CL. Relationships between epistaxis, migraines, and triggers in hereditary hemorrhagic telangiectasia. Laryngoscope 2014; 124: 1521–1528.
    1. Shovlin CL. Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia. Front Genet 2015; 6: 101.
    1. Hébert PC, Van der Linden P, Biro G, et al. . Physiologic aspects of anaemia. Crit Care Clin 2004; 20: 187–212.
    1. Dupuis-Girod S, Chesnais AL, Ginon I, et al. . Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study. Liver Transpl 2010; 16: 340–347.
    1. Hoag J, Terry P, Mitchell S, et al. . An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope 2010; 120: 838–843.
    1. Silva BM, Hosman AE, Devlin HL, et al. . Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia. Laryngoscope 2013; 123: 1092–1099.
    1. Shovlin CL, Gilson C, Busbridge M, et al. . Can iron treatments aggravate epistaxis in some patients with hereditary hemorrhagic telangiectasia? Laryngoscope 2016. [in press DOI: ].
    1. Mollet IG, Patel D, Govani FS, et al. . Low dose iron treatments induce a DNA damage response in human endothelial cells within minutes. PLoS One 2016; 11: e0147990.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner